Mather Group
AVNS icon

Mather Group’s Avanos Medical AVNS Stock Holding History

Mather Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-8
Closed -$199 – 2256
2026
Q2 		$199 Hold
8
– – ﹤0.01% 1865
2026
Q1 		$112 Buy
+8
New +$108 ﹤0.01% 1865
2025
Q4 		– Sell
-8
Closed -$92 – 723
2025
Q3 		$92 Buy
+8
New +$94 ﹤0.01% 1685
2025
Q2 		– Sell
-8
Closed -$115 – 691
2025
Q1 		$115 Sell
8
-8
-50% -$125 ﹤0.01% 1757
2024
Q4 		$255 Hold
16
– – ﹤0.01% 1688
2024
Q3 		$384 Hold
16
– – ﹤0.01% 1632
2024
Q2 		$319 Buy
+16
New +$312 ﹤0.01% 2100

Other funds holding AVNS

Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
B
Bayban Bayport, Minnesota $130M AUM 21.7% 1-Year Est. Return

Mather Group's AVNS Position: Q3 2026 in Review

Mather Group sold out of Avanos Medical (AVNS) in Q3 2026, closing a stake of 8 shares — an estimated $199 sold.

Mather Group first reported a position in AVNS in Q2 2024 and held it in 7 quarters. The position peaked at $384 in Q3 2024. 3 funds tracked by Wall St. Rank hold AVNS as of Q3 2026.

  • Mather Group reported no remaining Avanos Medical position as of Q3 2026 after selling out during the quarter.
  • Mather Group sold 8 Avanos Medical shares in Q3 2026, an estimated $199.
  • Mather Group first reported a position in Avanos Medical in Q2 2024 and held it in 7 quarters.
  • Mather Group's Avanos Medical position peaked at $384 in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.